Thomas de Vlaam
Private Equity Investor at Pillar Co Management LLC
Profile
Mr. Thomas de Vlaam is a Partner at Pillar Co Management LLC.
Mr. de Vlaam was previously employed as a Founder & CEO by Amylon Therapeutics BV.
He received his undergraduate degree from the University of Groningen.
Thomas de Vlaam active positions
| Companies | Position | Start |
|---|---|---|
Pillar Co Management LLC
 Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 30/06/2022 |
Former positions of Thomas de Vlaam
| Companies | Position | End |
|---|---|---|
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | 30/05/2022 |
Training of Thomas de Vlaam
| University of Groningen | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Finance |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Thomas de Vlaam
